Revenue surges 29% but profits collapse 29% as subs bleed cash
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Delivered on revenue growth vs prior 10-15% guidance, but deferred Packaging to H1 FY28 and no numeric H2 guidance.
Cautiously Optimistic
next 1–2 quarters
Cautiously Optimistic
multi-year
Core coding & marking business delivered strong 29% revenue growth and remains solid, but subsidiary losses (_5 Cr Q2) and R&D spend crushed PAT -29% YoY, signaling margin pressure. Long-term opportunity in Track & Trace (₹600-700 Cr market) is real but execution is delayed; management guidance is vague ('assuming no downward surprises'). Profit quality deterioration despite revenue growth is the key risk.
₹144.2 Cr
Revenue · +28.8% YoY₹13.1 Cr
Reported PAT · −29.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Consolidated revenue ₹144 Cr in Q2, up from ₹112 Cr in Q2 FY26
METDelivered ₹144.2 Cr, YoY +28.8% (from ~₹112 Cr). Math checks: (144-112)/112 = 28.6%, matches.
Coding & Marking is 94-95% of operating revenue, steady business with strong demand
METConfirmed by call but no segment revenue breakdown given. No evidence of slowdown in core, but also no acceleration.
Subsidiary losses on 'declining trend' from ₹36 Cr (FY26) to ~₹5-8 Cr per quarter now
METManagement cited Q2 losses ~₹5 Cr vs Q1 ~₹8 Cr vs FY26 ~₹36 Cr. Trend is improving, but at ₹5 Cr/Q, annualized ~₹20 Cr impact. Q2 PAT of ₹13.1 Cr suggests subsidies and losses are massive headwinds.
Core business targeting 60% gross margin, ~30% EBIT margin (excl. interest, tax, depreciation impacts)
OVERSTATEDManagement stated 60% gross profit target for coding & marking. COGS at 41.65% of revenue supports this. But delivered NPM is 9%, far below 30% EBIT claim.
H2 performance should be steady if no 'downward surprises'; QRiousCodes pilots concluding positively
PartialVague and hedged. Management did not give numeric H2 guidance. Iran impact Q1, subsidiary challenges ongoing, machinery delays for V-Shapes. Qualitative only.
Earnings quality
What changed since the last call
Subsidiary losses halved
UpgradeDeclining from ₹36 Cr FY26 to ~₹5 Cr Q2 FY27; cost-cutting in Italy/UK/Codeology underway. Still material but trending right.
Core revenue accelerated beyond guidance
UpgradePrior 10-15% FY27-end guidance now exceeded; Q2 showed +28.8% YoY. Coding & Marking segment steady and strong.
Packaging breakeven delayed again
DowngradePushed from FY27 to H1 FY28. V-Shapes machinery/team challenges cited; cost basis reduced 25% but timeline extended.
Net profitability significantly compressed
DowngradePAT -29.4% YoY despite revenue +28.8% YoY. Margin erosion from subs losses, employee costs, depreciation not offset by core pricing/efficiency gains.
The Q&A
Analysts pressed hard on subsidiary losses (Madhu Rathi on V-Shapes, Kewal Shah on breakdown, Aryan Kadam on minimization). Management was defensive, using long-term investment analogies (Amazon, Facebook) but offered no concrete recovery timeline. Jayesh Gandhi and Parag Hemdev questioned Track & Trace opportunity; management was cautious, citing NDAs and waiting for regulatory clarity. Overall, Q&A revealed analyst skepticism on execution and profitability outlook.
V-Shapes subsidiary strategy — Madhu Rathi, independent
DodgedIt's an execution issue, not demand. Scope is large; we're investing in IP-protected products like other tech companies (Amazon, Facebook lost money long-term). Progress is improving quarter-to-quarter, but timeline is uncertain.
Subsidiary loss breakdown — Kewal Shah, investor
AnsweredLosses trending down: ₹36 Cr FY26 → ₹8 Cr Q1 → ₹5 Cr Q2. It's structural but improving. Markprint is profitable YoY. Middle East (started Jan 2025) will break even this year. Codeology and V-Shapes are improving.
Coding & Marking EBIT target — Saket Kapoor, analyst
AnsweredTarget 60% gross profit (excluding R&D, warranty, etc.), ~30% EBIT margin. This includes depreciation impacts. Current quarter demonstrates the trend.
Track & Trace market size & timeline — Jayesh Gandhi, analyst
PartialMarket today ₹600-700 Cr. Government mandates on 300 brands started; more coming 2027-28. We're at breakeven, doing pilots. Can't disclose specifics due to NDA. Market growing but depends on government execution.
V-Shapes machinery & timeline — Samad Singh, analyst
PartialCost basis down 25% from original. Team restructured (65-70% staff replaced). Machinery issues identified, fixes ongoing. Retrofit design 70-80% done, maybe 30% right now. Next sets of machines by Jan-Feb. Timeline uncertain due to execution challenges.
FSSAI Track & Trace mandate traction — Parag Hemdev, analyst
AnsweredNot much in the market yet. We're focused on top 300 brands. Government is 99% of our focus, not smaller players. We're watching for gazette issuance, but it's early days.
International subsidiary profitability path — Aryan Kadam, investor
AnsweredMarkprint is already profitable YoY. Middle East (Jan 2025 start) will break even this year with good pipeline. Codeology/V-Shapes are in optimization phase; we're downsizing personnel and costs. These are long-term bets.
Guidance
Core Coding & Marking: 10-15% growth by FY27-end
HighQ2 delivered +28.8% YoY, well ahead. Management reaffirmed 'steady' outlook for H2, though no numeric target.
Track & Trace: breakeven by FY27 (unchanged)
MediumPilots ongoing, revenue immaterial. Government mandates 2027-28 key driver. No growth timeline.
Packaging/V-Shapes: breakeven by H1 FY28 (deferred from FY27)
LowMachinery delays, team challenges, timeline extended. Cost basis reduced 25% but progress still unproven.
Coding & Marking: 60% gross margin, ~30% EBIT target
MediumStated by management. COGS 41.65% supports gross margin; achieved EBIT would require <10% opex ratio.
Overall OPM (consolidated): 19.9% Q2, maintained
MediumNo explicit guidance, but management said 'assuming no downward surprises' performance should be maintained. Subsidiary losses drag overall margin.
Risks the call surfaced
Subsidiary execution risk
HighV-Shapes, Codeology, Italy/UK ops losing ₹5 Cr Q2. Machinery test results 30% complete (target 70-80% by year-end). Breakeven timeline uncertain; team restructuring (65-70% churn) creates execution risk.
Government regulatory dependency
MediumTrack & Trace opportunity depends on government implementation of 300+ brand mandates. Timing uncertain (2027-2028 cited). Market is ₹600-700 Cr today; expansion depends on regulator execution. Currently immaterial revenue.
Profit quality deterioration
HighPAT declined 29.4% YoY despite revenue +28.8% YoY. Subsidiary losses, increased employee costs, and R&D spending offset core margin gains. NPM 9.0% is low given core target of 30% EBIT.
Operational execution risk
MediumMultiple execution challenges: SAP implementation will require 3-4 month shutdown; V-Shapes machinery test cycles longer than expected; team restructuring in international ops causing friction (staff contracts in Italy). Supply-chain optimization for materials ongoing.
Supply/macro headwinds
LowIran-related supply issue impacted Q1 (management cited as headwind). Commodity (raw material) costs mentioned as Q1 pressure; management expects optimization in H2. International operations exposed to forex.
Management
Score 6/10. Mixed. Detailed on core business mechanics, but evasive on subsidiary specifics (NDAs cited for Track & Trace). Long-winded explanations without clear metrics. Candid on challenges (machinery delays, team churn) but defensive on loss trajectory. Inconsistent. Core business tracking ahead of guidance (+28.8% vs 10-15% guided). Subsidiaries tracking behind (breakeven deferred, losses still material). SAP, machinery, and team challenges cited as ongoing.
1 · Q3 FY27
QRiousCodes pilots conclusion with positive feedback; interim profitability milestones
2 · Q4 FY27
V-Shapes machinery commissioning, manufacturing cost reduction impact
3 · H1 FY28
Packaging/V-Shapes segment breakeven (deferred from FY27 guidance)
Profit quality deterioration despite revenue growth is the key risk.
Control Print Q2 FY27: consolidated PAT down 29% YoY on tax spike despite 29% revenue growth
PAT -29.37% YoY · revenue +28.82% · margins compressing
₹144.22 Cr
+28.82% YoY
₹13.13 Cr
-29.37% YoY
9%
-7.4pp YoY
₹8.21
Control Print's consolidated revenue rose 28.8% YoY to ₹144.22 Cr (and 24.8% QoQ from ₹115.56 Cr in Q1 FY27), but consolidated PAT — the primary basis — fell 29.4% YoY to ₹13.13 Cr from ₹18.59 Cr, with EPS down to ₹8.21 from ₹11.62. Sequentially PAT jumped 234.9% from Q1 FY27's depressed ₹3.92 Cr, but that QoQ bounce is off a weak base and does not offset the YoY decline, which is the primary read here.
Q2 FY-2027 vs prior quarters
The gap between strong topline growth and a weaker bottom line sits almost entirely in the tax line, not operations: consolidated operating profit margin held up reasonably (~19.9% this quarter vs ~13.2% in Q1 FY27, though down from ~23.2% a year ago), but the effective tax rate jumped to ~45.5% (₹10.97 Cr tax on ₹24.09 Cr PBT) from ~14.4% YoY, as the standalone deferred tax asset balance fell from ₹33.22 Cr at FY26-end to ₹27.87 Cr. Net profit margin compressed to 9.1% from 16.5% YoY as a result. Standalone PAT of ₹18.64 Cr (EPS ₹11.65) is materially higher than the consolidated figure, with non-controlling interest posting a ₹0.89 Cr loss this quarter — consistent with the Packaging business still being pre-breakeven, as management had guided breakeven only for H1 FY28, not this quarter.
The stock went into the print at ₹605.55, up 2.5% over the past month of trading.
For context: revenue is at a 6-quarter high.
Core Coding & Marking expected 10–15% growth by FY27-end (from prior run-rate guide). Packaging business pushed to H1 FY28 breakeven (deferred from FY27). Track & Trace ₹20 Cr annual revenue at breakeven.
— This quarter: beat
Management's prior guidance (Q1 FY27 call) called for 10–15% core Coding & Marking revenue growth by FY27-end; the 28.8% YoY print clears that bar comfortably on the topline, even as the prior call's defensive tone and high-risk framing proved warranted on the profit side given the tax-driven miss. No management press release was available in the filing to cross-check this quarter's framing, and no analyst street estimates for Q2 FY27 specifically were found pre-result (the quarter's results were announced today), so vsStreet is unknown. During the quarter the company signed an IP Assignment Agreement with step-down subsidiary CP Italy S.R.L. for ₹31.20 Cr (₹3,120.11 Lakh / EUR 28.60 Lakh), now carried as intangible assets under development, and promoter-linked investor Basant Kumar Kabra raised his stake by 2.24% in the days just before results.
W1
Whether the ~45.5% consolidated effective tax rate normalizes in H2 FY27 — deferred tax asset base now ₹27.87 Cr, down from ₹33.22 Cr at FY26-end.
W2
Progress of the Packaging business toward its guided H1 FY28 breakeven — still a drag on consolidated PAT versus standalone this quarter.
W3
Whether core Coding & Marking revenue growth (28.8% YoY this quarter) sustains for the rest of FY27 against the 10–15% full-year guidance band it is currently exceeding.
Revenue Surges 29%, Profit Crashes 29% — The Margin Compression Story
Control Print's core business is firing on all cylinders, but subsidiary losses and R&D spending have crushed profitability. The quarter shows a company unable to translate top-line growth into earnings expansion — the real issue beneath the headline.
₹144.2 Cr
+28.8% YoY
₹13.1 Cr
-29.4% YoY
9.0%
-270 bps YoY
Control Print delivered the revenue growth it promised — up 29% YoY, ahead of prior 10–15% guidance — but the profit print tells a painful story. Net profit fell 29% year-on-year even as the top line surged. The margin compressed 270 basis points. This is not a blowout quarter; it's a window into why the stock is down 47% from its all-time high.
Where the margin went
The core Coding & Marking business — which accounts for 94–95% of operating revenue — is performing as advertised: steady demand, double-digit growth, and a stated target of ~30% EBIT margin. But consolidated net profit margin of 9% tells you the whole company is not capturing that. Three items consumed the uplift:
Subsidiary losses: ~₹5 Cr in Q2 (₹20 Cr annualized), down from ₹36 Cr in FY26 but still material
R&D and depreciation spending on new bets (V-Shapes, Track & Trace, QRiousCodes)
Employee costs at 17% of revenue, down from 18% prior year but still elevated
Core COGS is stable at 41.65% of revenue — the manufacturing discipline is intact. But the company is essentially funding three growth bets (Track & Trace at breakeven, V-Shapes in development with ₹5 Cr Q2 losses, and QRiousCodes pilots still running) out of the core business cash, and that's translating directly to bottom-line margin compression.
Coding & Marking 94–95% of revenue, steady business with strong demand
✓ Confirmed by call; no segment slowdown cited. Core revenue growth estimated ~30% at the segment level.
Supported
Core segment targeting 60% gross margin, ~30% EBIT margin
Gross margin math checks (COGS 41.65% → 58% gross). But consolidated NPM 9% vs. claimed 30% EBIT shows subsidiary losses and depreciation consume >50% of core profit.
Overstated (delivery gap)
Subsidiary losses on declining trend (₹36 Cr FY26 → ~₹5 Cr Q2)
✓ Math checks. Q1 ₹8 Cr, Q2 ₹5 Cr annualized ~₹20 Cr impact — still a headwind but improving.
Supported
H2 FY27 performance should be steady 'assuming no downward surprises'
Vague and fully hedged. No numeric guidance given. Prior guidance (10–15% growth) was beaten but baseline for H2 unclear.
Partial (hedged)
What changed on this call
Subsidiary losses halved Q1→Q2 (₹8 Cr → ₹5 Cr). Cost-cutting in Italy/UK and Codeology is showing results.
Core revenue accelerated beyond prior guidance (10–15% → delivered 28.8% YoY). Coding & Marking demand is hot.
Packaging/V-Shapes breakeven deferred again (was FY27 guidance, now H1 FY28). Machinery delays and team challenges continue.
Net profitability compressed sharply (−29% YoY). Revenue growth could not overcome subsidiary drag and R&D spending.
How the market is positioned
Price action: Control Print trades at ₹576, down 47% from an all-time high of ₹1,080. The stock is below its 20-day, 50-day, and 200-day moving averages — a bearish technical setup. RSI of 45 suggests the selling pressure has not yet been exhausted. The fundamental story (margin compression, profit collapse despite revenue growth) matches the technical weakness — there is no hidden bull case the market is ignoring.
Institutional positioning: FII ownership has ticked down from 3.15% to 3.07% since Q4 FY26. DII ownership is negligible (0.16% in Q1 FY27) and declining. Promoter holding steady at ~53%. This is not a stock foreign or domestic institutions are queuing up to buy at current prices. The bench is weak.
Valuation context: At ₹576, the stock is pricing in either (a) sustained 9% net margins, or (b) a belief that the subsidiary losses won't improve as fast as management claims. The 47% drawdown from all-time high is a correction, but it's earned — profit collapsed in this quarter despite revenue growth.
Core Coding & Marking revenue growth (29% YoY) delivered ahead of guidance
Subsidiary losses halving (₹36 Cr FY26 → ₹20 Cr annualized Q2 run-rate)
Market share in Coding & Marking intact (oligopoly of ~4 players at 80% market share)
Net profit collapsed 29% YoY despite revenue up 29%
Net margin compressed 270 bps to 9% — lowest run-rate in recent memory
Packaging/V-Shapes breakeven deferred multiple times; machinery delays ongoing
H2 guidance entirely qualitative; management credibility on timelines is weak
FII and DII ownership both declining; institution confidence low
Risks, ranked by severity
Profit quality deterioration
HighRevenue +29% YoY but PAT −29% YoY is not sustainable. Margin compression of 750 bps is a structural issue, not cyclical. If subsidiaries don't improve faster or core business margins fall further, shareholders will see more downside.
Subsidiary execution delays and losses
High₹5 Cr Q2 loss (₹20 Cr annualized) from V-Shapes, Codeology, Italy/UK. While declining, still crushing consolidated profitability. Machinery test cycles are only 30% complete; Jan-Feb 2027 deadline is at risk.
Track & Trace regulatory dependency and pilot delays
Medium₹600–700 Cr market opportunity exists, but depends on government mandates (2027–28 timing) and pilot-to-revenue conversion (Q3 FY27 target). Currently immaterial revenue and at breakeven. Any delay in government implementation pushes revenue upside out 12+ months.
Management guidance credibility
MediumPackaging breakeven deferred FY27 → H1 FY28 multiple times. H2 FY27 guidance is 'steady if no surprises' with no numbers. Analysts pressed hard on V-Shapes and losses; management was defensive. If H2 disappoints, stock could re-test lows.
Operational execution (SAP, machinery, team restructuring)
Medium3–4 month SAP implementation will impact operations. V-Shapes team has 65–70% staff turnover. Material sourcing optimization ongoing. Any of these can delay profitability recovery further.
1 · H2 FY27 net profit and margin trajectory
If the company stabilizes net margin above 10% in Q3–Q4 FY27, it signals subsidiary losses are truly abating and core business pricing power is intact. If margin stays near 9%, it suggests structural headwinds. This is the number to track.
2 · V-Shapes machinery commissioning results
Jan-Feb 2027 delivery of next set of machines is critical. If the retrofit design and cost-basis reductions translate to on-time delivery and lower COGS, Packaging/V-Shapes credibility is restored. If delayed again, deferred breakeven is pushed to FY28 or beyond.
3 · Track & Trace pilot-to-revenue conversion
QRiousCodes pilots conclude in Q3 FY27. Management needs to announce customer wins, signed deals, or revenue targets from those pilots. If pilots conclude with 'encouraging feedback' but no deals, the ₹600–700 Cr opportunity remains theoretical, not real.
Control Print's core business is firing. But the quarter is a reminder that top-line growth without bottom-line expansion is incomplete — and in this case, it's a red flag, not a growth story. The company is at an inflection: it needs to (1) prove subsidiaries can return to breakeven or profit, and (2) convert the Track & Trace opportunity from pilots to revenue. Until then, the margin compression and profit collapse despite revenue growth will keep institutional buyers on the sidelines.
The honest read: This is steady execution on the core, not a step-change. The number to track from here is net margin — can it stabilize above 10% by Q4 FY27, or is 9% the new baseline? That single line item will determine whether the stock finds support or re-tests its lows.